UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) Delaware 23-2077891 (State or other jurisdict ...

Core Viewpoint - Analysts project that Universal Health Services (UHS) will report quarterly earnings of $5.91 per share, reflecting a 20.1% year-over-year increase, with revenues expected to reach $4.48 billion, a 9% increase from the same quarter last year [1] Group 1: Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating analysts' reassessment of their initial projections [1][2] - Changes in earnings estimates are crucial for predicting potential investor reactions to the stock, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [2] Group 2: Revenue Projections - Analysts estimate 'Net Revenues- Acute care hospital services' at $2.51 billion, representing an 8.3% increase from the previous year [4] - 'Net Revenues- Behavioral health services' are projected to be $1.97 billion, indicating a year-over-year change of 10% [4] Group 3: Operational Metrics - The average prediction for 'Admissions - Behavioral health' is 121,441, up from 114,684 in the same quarter last year [5] - 'Operating Income- Behavioral Health Care Services' is expected to reach $436.21 million, compared to $360.85 million reported in the same quarter last year [5] - 'Operating Income- Acute Care Hospital Services' is projected at $245.66 million, an increase from $220.87 million in the same quarter last year [6] Group 4: Stock Performance - Over the past month, Universal Health Services shares have gained 11.8%, while the Zacks S&P 500 composite has decreased by 0.8% [6] - UHS holds a Zacks Rank 2 (Buy), suggesting it is likely to outperform the overall market in the upcoming period [6]

Core Insights - The article emphasizes the importance of data-driven insights in maximizing profitability within the finance and property management sectors [1]. Group 1: Company Profile - The company operates in the property management industry in Istanbul, focusing on financial modeling, market analysis, and investment research [1]. - It has over two years of experience in applying data analytics to develop budgets and set targets [1]. Group 2: Industry Trends - The integration of data analytics in finance is becoming increasingly vital for making informed investment decisions [1]. - The article highlights the growing significance of cryptocurrency alongside traditional stock investments in the current market landscape [1].

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those that can fulfill their potential is challenging [1] Group 1: Company Overview - Universal Health Services (UHS) is highlighted as a recommended growth stock with a favorable Growth Score and a top Zacks Rank [2][10] Group 2: Earnings Growth - Historical EPS growth rate for Universal Health Services is 10.9%, with projected EPS growth of 7.9% this year, significantly outperforming the industry average of -3.9% [5] Group 3: Asset Utilization - Universal Health Services has an asset utilization ratio (sales-to-total-assets ratio) of 1.14, indicating higher efficiency compared to the industry average of 0.82 [7] - The company's sales are expected to grow by 5.2% this year, surpassing the industry average of 3.3% [7] Group 4: Earnings Estimate Revisions - Current-year earnings estimates for Universal Health Services have been revised upward, with the Zacks Consensus Estimate increasing by 0.4% over the past month [8]

Core Viewpoint - The article highlights Universal Health Services (UHS) as a strong growth stock, supported by its favorable Growth Score and Zacks Rank, indicating solid investment potential for growth investors [2][11]. Earnings Growth - Universal Health Services has a historical EPS growth rate of 10.9%, with projected EPS growth of 7.8% this year, significantly outperforming the industry average of -1.6% [5][4]. Asset Utilization Ratio - The company has an asset utilization ratio (sales-to-total-assets) of 1.14, indicating it generates $1.14 in sales for every dollar in assets, compared to the industry average of 0.82, showcasing superior efficiency [7][6]. Sales Growth - UHS is expected to achieve a sales growth of 5.2% this year, which is higher than the industry average of 4.2%, reflecting strong sales performance [8]. Earnings Estimate Revisions - The current-year earnings estimates for Universal Health Services have been revised upward, with the Zacks Consensus Estimate increasing by 0.4% over the past month, indicating positive momentum [9]. Overall Assessment - With a Zacks Rank of 2 and a Growth Score of B, Universal Health Services is positioned as a potential outperformer and a solid choice for growth investors [11].

Group 1 - Universal Health Services, Inc. (NYSE: UHS) experienced a drop of over 6% on Wednesday but is trading marginally higher on Thursday following Bank of America's cautious stance on hospitals [1] - The stock is considered oversold and at a support level, which could indicate bullish dynamics and a potential upward movement [2][5] - The concept of reversion to the mean suggests that after significant movement in one direction, a reversal is likely, supported by statistical and probability theories [2][3] Group 2 - The stock is currently below the Bollinger Band, which is two standard deviations under the 20-day moving average, indicating it is oversold [4] - Anticipation of a reversion to the mean may draw buyers into the market, potentially leading to an uptrend for the stock [5][6] - The stock has reached a support level around $208, which was previously a resistance level, creating a base for potential buying activity [5][6]

Core Viewpoint - Universal Health Services (UHS) is highlighted as a strong investment opportunity with a Zacks Rank 1 (Strong Buy) and a 6.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1]. Group 1: Company Overview - Universal Health Services operates a diverse range of healthcare facilities, including acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers [1]. - The company has a price-to-earnings ratio (P/E) of 10.32, significantly lower than the S&P average of 25.11, indicating strong value characteristics [2]. - Universal Health Services holds a Value Score of A, further emphasizing its attractiveness to value-focused investors [2].

Core Viewpoint - Universal Health Services (UHS) has shown strong performance in its recent earnings report, with significant growth in earnings and revenues, leading to an upward revision of its financial guidance for 2025 [3][11]. Financial Performance - UHS reported Q3 2025 adjusted earnings per share (EPS) of $5.69, exceeding the Zacks Consensus Estimate by 22.1% and reflecting a year-over-year increase of 53.4% [3]. - Net revenues reached $4.5 billion, marking a 13.4% year-over-year improvement and surpassing the consensus estimate by 4.2% [3]. - Adjusted EBITDA rose 27.4% year over year to $670.6 million, exceeding the estimate of $577.4 million [5]. Segment Performance - In Acute Care Hospital Services, adjusted admissions grew 2% on a same-facility basis, with net revenues improving 12.8% [6]. - Behavioral Health Care Services saw adjusted admissions increase by 0.5%, with net revenues rising 9.3% on a same-facility basis [7]. Operational Costs - Total operating costs for the quarter were $4 billion, an 11% increase year over year, driven by higher salaries, wages, and benefits [5]. Financial Position - As of September 30, 2025, UHS had cash and cash equivalents of $112.9 million, down 10.4% from the end of 2024 [8]. - Long-term debt decreased by 11.5% year over year to $4 billion, while total equity increased by 7.1% to $7.2 billion [9]. Share Repurchase Program - UHS repurchased shares worth approximately $234.3 million in Q3 and approved a $1.5 billion increase to its stock repurchase program, bringing the total remaining authorization to $1.8 billion [10]. Revised Guidance - The company revised its 2025 net revenue guidance to a range of $17.306-$17.445 billion, indicating a projected growth of 9.8% from 2024 [11]. - EPS is now expected to be between $21.50 and $22.10, reflecting a 31.2% growth from the previous year [12]. Market Outlook - Estimates for UHS have been trending upward, and the stock currently holds a Zacks Rank 2 (Buy), suggesting an expectation of above-average returns in the coming months [15].

Core Insights - Universal Health Services, Inc. (UHS) is a healthcare company that provides care and receives reimbursement through Medicare, Medicaid, and individual insurance plans [1] - UHS owns a small insurance subsidiary known as Prominence Health, which serves as a part of its operations [1] Company Overview - UHS operates primarily in the healthcare sector, focusing on providing care and managing reimbursements from various government and private insurance programs [1] - The company has diversified its operations by owning Prominence Health, enhancing its service offerings [1]

Core Insights - The company has experienced a largely expected performance in the third quarter, with notable positive and negative surprises [2] - A significant positive factor was the receipt of approximately $90 million in annual DPP payments from Washington, D.C., which had been pending CMS approval [2] - The company is now operating in a post-COVID environment, with business models returning to more historically normative patterns [3] Financial Performance - The company reported mid-single digit same-store revenue growth, with acute care revenue growth in the range of 5.5% to 6% [3] - The growth is evenly split between different business segments, indicating a balanced performance across operations [3] Future Outlook - The company anticipates continued alignment with historical performance models as it moves towards 2026 [3]